Irinotecan in advanced lung cancer: focus on North American trials. [electronic resource]
Producer: 20040930Description: 17-28 p. digitalISSN:- 0890-9091
- Antimetabolites, Antineoplastic -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Camptothecin -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Carcinoma, Small Cell -- drug therapy
- Cisplatin -- administration & dosage
- Deoxycytidine -- administration & dosage
- Enzyme Inhibitors -- administration & dosage
- Etoposide -- administration & dosage
- Humans
- Irinotecan
- Lung Neoplasms -- drug therapy
- North America
- Radiotherapy, Adjuvant
- Ribonucleotide Reductases -- antagonists & inhibitors
- Survival Rate
- Taxoids -- administration & dosage
- Topoisomerase I Inhibitors
- Vindesine -- administration & dosage
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.